Literature DB >> 23675836

Antimicrobial activities of some mushrooms in Turkey.

Hasan Hüseyin Doğan1, Rüstem Duman, Birol Özkalp, Sema Aydin.   

Abstract

CONTEXT: Terfezia boudieri Chatin (Pezizaceae), Agaricus brunnescens Peck (Agaricaceae) and Lactarius vellereus (Fr.) Fr. (Russulaceae) are well-known species in Turkey, and are used both for food and traditional medicine.
OBJECTIVE: The powdered fruit bodies of T. boudieri, A. brunnescens and L. vellereus were used to evaluate the antimicrobial activities.
MATERIALS AND METHODS: Chloroform, acetone and methanol extracts of T. boudieri, A. brunnescens and L. vellereus were tested for their antimicrobial activities against four Gram-positive bacteria, five Gram-negative bacteria and yeast using a micro-dilution method.
RESULTS: The strongest minimum inhibitory concentration (MIC) value observed against the test microorganisms was with the chloroform extract of T. boudieri (MIC 2.4 µg/mL) against Streptococcus pyogenes. Maximum antimicrobial effects were observed with the acetone extracts of T. boudieri and L. vellereus (MIC 4.8 µg/mL) against Bacillus subtilis. The strongest antifungal activity was observed with the acetone extracts of T. boudieri (MIC 2.4 µg/mL) and A. brunnescens (MIC 19.5 µg/mL) against Candida albicans. The strongest MIC values for all fungal extracts were observed between 78 and 2.4 µg/mL. DISCUSSION AND
CONCLUSION: Present results demonstrated that these three mushroom species have excellent antimicrobial and antifungal activities, and thus have great potential as a source for natural health products.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23675836     DOI: 10.3109/13880209.2013.764327

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  1 in total

Review 1.  A Review on Antistaphylococcal Secondary Metabolites from Basidiomycetes.

Authors:  Vimalah Vallavan; Getha Krishnasamy; Noraziah Mohamad Zin; Mazlyzam Abdul Latif
Journal:  Molecules       Date:  2020-12-11       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.